Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring.

@article{Yu2019UpdatesO1,
  title={Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring.},
  author={Wei-ye Yu and P. Lu and M. Assadi and Xi-Ling Huang and A. Skrahin and A. Rosenthal and A. Gabrielian and Michael Tartakovsky and Y{\`i} Xi{\'a}ng J. W{\'a}ng},
  journal={Quantitative imaging in medicine and surgery},
  year={2019},
  volume={9 6},
  pages={
          1132-1146
        }
}
  • Wei-ye Yu, P. Lu, +6 authors Yì Xiáng J. Wáng
  • Published 2019
  • Medicine
  • Quantitative imaging in medicine and surgery
Tuberculosis (TB) is currently the world's leading cause of infectious mortality. The complex immune response of the human body to Mycobacterium tuberculosis (M.tb) results in a wide array of clinical manifestations, thus the clinical and radiological diagnosis can be challenging. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) scan with/without computed tomography (CT) component images the whole body and provides a metabolic map of the infection, enabling clinicians to assess… Expand
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation
TLDR
An Italian consensus document on 18F-fluorodeoxyglucose PET/CT or PET/MRI in inflammatory and infectious diseases, such as osteomyelitis, prosthetic joint infections, infective endocarditis, is hoped to be the basis for a “common nuclear physicians’ language” throughout all the country. Expand
Role of 18F-FDG PET/CT in the Assessment of Response to Antitubercular Chemotherapy and Identification of Treatment Endpoint in Patients With Tuberculosis of the Joints: A Pilot Study.
TLDR
18F-FDG PET/CT is an excellent tool in estimating total disease burden, assessing response to ATT and identification of treatment endpoint in joint tuberculosis. Expand
[18F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis
Objective: In extra-pulmonary tuberculosis, therapeutic management is difficult in the absence of reliable tool to affirm healing at the end of treatment. In this prospective multicenter study, weExpand
Is 18F-FDG PET/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma?
TLDR
Evaluation of increased pleural FDG uptake together with the detected parenchymal findings and lymphatic involvement may help to make more accurate interpretation of the diagnosis of tuberculosis pleurisy in tuberculosis endemic countries. Expand
Characterization of 18F-fluorodeoxyglucose metabolic spatial distribution improves the differential diagnosis of indeterminate pulmonary nodules and masses with high fluorodeoxyglucose uptake.
TLDR
Pulmonary benign and malignant lesions have distinct FMSD characteristics and V-FMSD can therefore be used as a novel auxiliary marker to improve the diagnostic accuracy of hypermetabolic indeterminate pulmonary nodules and masses. Expand
Controversies and Pitfalls in the Diagnosis of Extrapulmonary Tuberculosis with a Focus on Genital Tuberculosis
TLDR
Molecular tests have improved time-to-detection for disease and drug sensitivity testing; however, they cannot replace culture testing at present and though specificity of molecular testing is high, sensitivity varies in samples from different sites, being low for TB meningitis. Expand
Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance
TLDR
While EPTB due to MTBC responds to first-line anti-TB drugs (ATD), drug susceptibility profiling is an essential criterion for addressing drug-resistant E PTB cases (DR-EPTB). Expand
Latent Tuberculosis and HIV Infection
TLDR
Antiretroviral therapy and tuberculosis-preventive treatment regimens can be optimized to avoid drug–drug interactions, decrease pill burden and duration, and minimize side effects in order to increase adherence and treatment completion rates among PWH and LTBI. Expand
Temporal and Spatial Analyses of TB Granulomas to Predict Long-Term Outcomes
TLDR
A temporal and spatial analysis framework for TB granulomas is developed using a systems biology approach combining in silico granuloma modeling, geographic information systems, topological data analysis, and machine learning to enable better understanding and prediction ofgranuloma behaviors that have known associations with poor clinical outcomes for TB patients. Expand
Биомаркеры и иммунологические тесты. Экспериментально-клинические параллели латентной туберкулезной инфекции
TLDR
The article describes experiments on latent tuberculosis infection on Cynomolgus macaques and analyzes publications that experimentally show the spectrum of the immune response to MTB-specific proteins ESAT-6 and CFP10 in case of tuberculosis infection, in particular, the relationship between the cytokine response and bacterial load. Expand
...
1
2
...

References

SHOWING 1-10 OF 64 REFERENCES
Value of FDG-PET/CT for treatment response in tuberculosis: a systematic review and meta-analysis
TLDR
Despite high heterogeneity there was a trend towards the usefulness of FDG-PET or FDg-PET/CT for evaluation of ATT response, and Impending research is needed to further clarify the predictive value of FDGPET/CT in tuberculous disease. Expand
Advances in imaging of tuberculosis: the role of 18F-FDG PET and PET/CT
TLDR
Evaluation of treatment response is potentially the most important clinical application of 18F-FDG PET in TB, owing to its ability to distinguish active from inactive disease. Expand
(18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
  • V. Martinez, M. Castilla-Lièvre, +5 authors F. Boué
  • Medicine
  • The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2012
TLDR
F-FDG PET/CT allows an easy evaluation of early therapeutic response in patients with TB, particularly extra-pulmonary TB. Expand
18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis
TLDR
Both components of 18F-FDG PET/CT provide complementary information at initial evaluation and during follow-up; however, 18F -FDG showed more abnormal findings than CT. Expand
18-fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series
TLDR
FDG-PET may possess a role in the diagnosis of active TB infection in settings where conventional microbiological methods are unavaiable and holds particular promise for monitoring response to therapy in cases of unsettled treatment duration such as multidrug-resistant TB or in extrapulmonary TB. Expand
Clinical usefulness of 18F-FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis.
TLDR
FDG PET/CT allows an accurate pre-therapeutic mapping of LNTB and helps for early TB confirmation and the SUVmax follow up is a potential tool for monitoring the treatment response. Expand
Evaluation of Therapeutic Response of Tuberculoma Using F-18 FDG Positron Emission Tomography
TLDR
PET scans may be useful for monitoring responses to anti-TB treatment in patients with tuberculosis, and changes in maximal standard uptake value of the tuberculoma on PET images were analyzed between 2 scans. Expand
Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated Tuberculosis
TLDR
A cutoff of 5 or more involved lymph node bastions allowed for separation of tuberculostatic responsive and nonresponsive tuberculosis-infected HIV patients with a sensitivity of 88, a specificity of 81%, and a negative predictive value of 93%. Expand
18F-FDG Positron-Emission Tomography/Computed Tomography Findings of Radiographic Lesions Suggesting Old Healed Tuberculosis
TLDR
Given that the factors associated with increased FDG uptake are known risk factors for TB development, the possibility exists that participants with old healed TB lesions with higher SUV on 18F-FDG PET/CT scans might be at higher risk for active TB. Expand
PET/CT imaging of Mycobacterium tuberculosis infection
TLDR
PET/CT provides a noninvasive and sensitive method of assessing histopathological information on different aspects of tuberculosis and is already playing a role in the management of tuberculosis. Expand
...
1
2
3
4
5
...